Develops drugs for rare diseases.
Dec 2025Revenue $7.67M/yrExpenses $29.1M/yr
No trendCash runway ≈ 4.8 years from Dec 2025
Figures by year
When will Adagene be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $7.67M and expenses $29.1M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $7.67M | $29.1M | −$21.4M |
| Dec 2024 | $103K | $36.1M | −$36.0M |
| Dec 2023 | $18.1M | $41.8M | −$23.7M |
| Dec 2022 | $9.29M | $93.2M | −$83.9M |
| Dec 2021 | $10.2M | $82.5M | −$72.4M |
| Dec 2020 | $701K | $43.9M | −$43.2M |
| Dec 2019 | $480K | $19.6M | −$19.2M |
| Dec 2018 | $1.51M | $18.8M | −$17.3M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.